Alecensa
Alecensa Alecensa (generic afatinib) is an irreversible epidermal growth factor receptor (EGFR) tyrosine‑kinase inhibitor (TKI) indicated for patients with metastatic or unresectable non‑small cell lung cancer (NSCLC) harboring EGFR‑exon 19 deletions or…